Login / Signup

Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.

Chuanliang CuiYu ChenZhiguo LuoZhengyun ZouYu JiangHongming PanQingxia FanJianfu ZhaoQing XuRenbing JiangXuan WangTaiyang MaZhen GuoLu SiZhihong ChiXinan ShengYiwei DouQian TanDi WuJun Guo
Published in: BMC cancer (2023)
Clinicaltrials.gov Identifier: NCT04749485 (registered retrospectively on 11/02/2021).
Keyphrases
  • monoclonal antibody
  • phase ii study
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • cross sectional
  • double blind
  • open label
  • lymph node